Recurrent Gastric Cancer Terminated Phase 1 Trials for Capecitabine (DB01101)

Also known as: Gastric cancer recurrent / Stomach cancer recurrent / Stomach carcinoma recurrent / Gastric carcinoma recurrent

IndicationStatusPhase
DBCOND0028800 (Recurrent Gastric Cancer)Terminated1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01233505Veliparib, Oxaliplatin, and Capecitabine in Treating Patients With Advanced Solid TumorsTreatment